Schizophrenia Clinical Trial
— SOSOfficial title:
Effectiveness of a Joint Crisis Plan (SOS Plan) in Preventing Relapses in Patients Diagnosed With Schizophrenia and Schizoaffective Disorder
The Joint Crisis Plan = SOS Plan is a reference to a particular form of psychiatric advance
directive which involves the patient, the healthcare team, their relatives and a third party
caregiver as intermediary for the project.
The main objective is to evaluate the effectiveness of the SOS Plan (JCP) in terms of the
reduction in hospitalisations within 18 months of its development by comparison to the
standard psychiatric care.
Thus, the investigators' proposal is that SOS Plan's are regularly reassessed every 6 months
and again where there is an unplanned psychiatric readmission that lasts beyond two weeks.
Single blind multicentre randomised trial with parallel control groups.
Effectiveness study of a psychiatric care strategy.
Status | Recruiting |
Enrollment | 210 |
Est. completion date | July 2022 |
Est. primary completion date | January 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Aged between 18 and 65 years - Diagnosed with schizophrenia or schizoaffective disorder according to criteria specified in DSM - Psychiatric inpatient or an outpatient with a specialised framework of psychiatric follow-ups - Patient has been hospitalised at least once in a psychiatric department within the previous 2 years - Adults under protective measures can be included (guardianship/supervision). Consent will also be sought from the guardian or trusted person. - Registered for social security Exclusion Criteria: - Refusal to participate in the study - Unable to give his or her written consent - Patients detained - Pregnant or lactating women |
Country | Name | City | State |
---|---|---|---|
France | University Hospital, Brest | Brest | |
France | University Hospital, Caen | Caen | |
France | University Hosiptal, Lille | Lille | |
France | Sainte-Anne Hospital, Paris | Paris |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille | Ministry of Health, France |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | incidence of the first psychiatric hospitalisation | the incidence of the first psychiatric hospitalisation within 18 months following inclusion | 18 months | |
Secondary | cumulative time in days of psychiatric hospitalisations | the cumulative time, in days, of psychiatric hospitalisations in the two years following inclusion | 2 years | |
Secondary | types of psychiatric hospitalisations | the types of psychiatric hospitalisation: voluntary (SL) or compulsory (SDT) | 2 years | |
Secondary | number of hospitalisations | the number of hospitalisations for each subject | 2 years | |
Secondary | number of emergency psychiatric consultations | the number of emergency psychiatric consultations | 2 years | |
Secondary | clinical assessment by the PANSS scale | PANSS score (intensity and qualitative aspects of the clinical situation) | every 6 months during 2 years | |
Secondary | patient satisfaction | score at a numeric scale of patient satisfaction | every 6 months during 2 years | |
Secondary | Autonomy Preference Index | decision making-autonomy assessment | every 6 months during 2 years | |
Secondary | Working Alliance Inventory | the working alliance assessment | every 6 months during 2 years | |
Secondary | length of the meeting to develop the SOS Plan | the length of the meeting to develop the SOS Plan in minutes | every 6 months during 2 years | |
Secondary | SF-36 quality of life | quality of life assessment by the SF-36 | every 6 months during 2 years | |
Secondary | medical cost | numbers of hospitalisations, of consultations, drugs consummation | every 6 months during 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |